10th International Conference on HHV-6 & 7 – Berlin, July 23-26

Find out more about registering at the 2017 Conference on HHV-6 & 7 in Berlin, Germany from July 24th-26th.
Stem cell transplant patients with HHV-6 reactivation are 15X more likely to reactivate with CMV

Italian investigators found that 87% of patients with HHV-6 reactivations went on to develop a CMV infection. On the other hand, in patients who did not reactivate with HHV-6, only 33% developed an active CMV infection.
miRNA changes by HHV-6A parallel those found in autoimmune thyroid disease

Investigators by at the University of Ferrara report intriguing alterations in intracellular regulation of HHV-6A-infected thyrocytes and T cells. HHV-6A, but not HHV-6B nor HHV-7, altered expression of several microRNAs in a pattern that is considered a marker for patients with autoimmune thyroid disease.
New mouse model for HHV-6 & 7

Investigators at Washington University have sequenced a murine herpesvirus and determined that it is closely related to HHV-6 & 7. Named Murine Rosesolovirus (MRV), the virus causes severe depletion of CD4+ T cells and thymic necrosis in young mice. The authors believe that MRV will be a useful mouse model to study the impact of HHV-6 & 7 in humans.

Newsletter | About Us | Contact Us | Donate | Repository

HHV-6 Foundation | HHV-6 Disease Information for Patients, Clinicians, and Researchers | Apply for a Grant

Navigation

Home
About
Patients
Research
Clinicians
Conditions
- Associated Conditions A-H
- Associated Conditions I-Z

Home
About
Patients
Research
Clinicians
Conditions
- Associated Conditions A-H
- Associated Conditions I-Z

Latest Treatments – Alternative Articles

Can a novel free radical scavenger help patients with HHV-6 encephalopathy?

In All, Encephalitis & Encephalopathy, News, Treatments - Alternative by hhv6foundationOctober 27, 2014

Edaravone shows promise for reducing oxidation and neuronal damage in AESD.

Successful use of Artesunate to treat HHV-6B myocarditis in a child

In All, Heart Disease, News, Treatments - Alternative by hhv6foundationApril 4, 2013

A group from Children’s Heart Centre in Lund, Sweden, has used Artesunate as an effective antiviral therapy to aid in the treatment of a child with HHV-6B myocarditis.

HHV-6 Conference

2017 International Conference in Berlin, Germany

Previous Conferences

Summary and Videos from the November 2015 Conference

Clinical News

Alzheimer’s Disease
Animal Models
Autoimmune Disease
Bell’s Palsy
Cancer
Chronic Fatigue Syndrome
ciHHV-6
Cognitive Dysfunction
Drug Hypersensitivity
Encephalitis & Encephalopathy
Epilepsy and Seizures
GVHD
Heart Disease
HIV/AIDS Progression
Infertility & Miscarriage
Kidney Disease
Liver Disease
Lymphadenitis
Multiple Sclerosis

Scientific News

Latest Scientific News
Genes & Proteins
Host Cell Interaction
Immunology

About HHV-6

What Is HHV-6?
What is Chromosomally Integrated HHV-6
HHV-6 Repository of Reagents
HHV-6A/B Testing
HHV-6 Treatment

SUBSCRIBE TO OUR NEWSLETTER

ABOUT THE HHV-6 FOUNDATION

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B.

The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge.

HHV-6 Foundation | 1482 East Valley Road, Suite 619 | Santa Barbara, CA, 93108 | Toll Free: (888) 530-6726

WEB DESIGN AND DEVELOPMENT BY INSTYLE TECHNOLOGIES

Home
About
Conditions
Clinicians
Testing
Research
Repository
Patients
Treatment
News & Blog
Donate
Contact Us
Cart
Checkout
Privacy Policy
Terms of Use